SCHEMBL24601423

SCHEMBL24601423

c1ccc(-c2cccc(-c3ccccc3)c2-c2ccc3c4c5c6ccccc6n6c7cc(-c8c(-c9ccccc9)cccc8-c8ccccc8)ccc7c(c7c8ccccc8n(c3c2)c74)c56)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.35
KDM4E B2RXH2 2/20 0.34
KMT2A Q03164 2/20 0.34
MEN1 O00255 1/20 0.34
MAPT P10636 1/20 0.34
RECQL P46063 1/20 0.34
PLEC Q15149 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
MAPK14 Q16539 1/20 0.33
HTR6 P50406 2/20 0.32
F9 P00740 1/20 0.32
ENPP1 P22413 1/20 0.32
ALDH1A1 P00352 1/20 0.31
HPGD P15428 1/20 0.31
CHEK1 O14757 1/20 0.31
CDK4 P11802 2/20 0.31
CCND1 P24385 2/20 0.31
MAOB P27338 1/20 0.31
HSD11B1 P28845 1/20 0.31
LMNA P02545 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24601624 1.00 HSD17B10 (0.35) HSD17B10KDM4EKMT2AMEN1MAPT
SCHEMBL24601497 0.97 HSD17B10 (0.35) HSD17B10KDM4EKMT2AMEN1MAPT
SCHEMBL24601522 0.94 F9 (0.32) KDM4EKMT2AMEN1MAPTRECQL
SCHEMBL24601509 0.93 HSD17B10 (0.34) HSD17B10KDM4EKMT2AMEN1MAPT
SCHEMBL24601510 0.93 MAOB (0.37) KDM4EKMT2AMEN1MAPTRECQL
SCHEMBL24601649 0.93 HSD17B10 (0.36) HSD17B10KDM4EKMT2AMEN1MAPT
SCHEMBL24601430 0.93 HSD17B10 (0.36) HSD17B10KDM4EKMT2AMEN1MAPT
SCHEMBL24601501 0.92 MAOB (0.35) KDM4EKMT2AMEN1MAPTRECQL
SCHEMBL24601519 0.92 MAOB (0.35) KDM4EKMT2AMEN1MAPTRECQL
SCHEMBL24601799 0.90 HSD17B10 (0.34) HSD17B10KDM4EKMT2AMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220213113-A1 NITROGEN-CONTAINING CONDENSED CYCLIC COMPOUNDS, FLUORESCENCE EMITTERS, ORGANIC ELECTROLUMINESCENT DEVICES, AND MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES SAMSUNG ELECTRONICS CO., LTD. (KR) 2022-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220213113-A1 NITROGEN-CONTAINING CONDENSED CYCLIC COMPOUNDS, FLUORESCENCE EMITTERS, ORGANIC ELECTROLUMINESCENT DEVICES, AND MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES NCL, NOC2L, NOLC1 HSD17B10 4661/4885KDM4E 3163/4885KMT2A 2774/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.